GLP‑1 doctors and weight loss clinics in Philadelphia, PA
1,096 clinicians in Philadelphia prescribed a GLP-1 to Medicare patients in 2024, over half of them internists and family doctors, and 3 clinicians there list obesity medicine as a specialty. You can contact one of them, or skip the search and start online with a program that serves Pennsylvania.
Data from CMS, NPPES and the US Census, read November 18, 2026.
Philadelphia at a glance
- Clinicians in Philadelphia wrote 71.2 Medicare GLP-1 claims per 1,000 residents in 2024: below the average of Pennsylvania’s largest cities (105.9) and about the same as the 500 largest US cities (70.0).
- Ozempic was the most prescribed, with 43% of those claims; semaglutide (Ozempic, Wegovy, Rybelsus) made up 49% and tirzepatide (Mounjaro, Zepbound) 14%.
- Of the 1,096 clinicians listed here, 617 are internists, family doctors or general practitioners and 60 are endocrinologists; 452 offer telehealth visits to Medicare patients, by CMS’s clinician file.
- 30 clinics, medical spas and practices in Philadelphia have a website that mentions semaglutide, tirzepatide or another GLP-1, and 7 mention compounded GLP-1s.
The top 3 online programs that serve Pennsylvania
Ranked by the glp1.health Score, which weighs safety and price transparency most, among the 31 programs we rate that serve Pennsylvania. We leave out any program with an open FDA warning letter. How we score · All rankings
We may earn a commission when you sign up through some links. It never changes our order or scores. How we make money
Where to get a GLP‑1 in person in Philadelphia
Practices in Philadelphia with GLP‑1 prescribers
Medicare group practices with a location in Philadelphia, by their clinicians’ GLP-1 prescriptions in 2024. The patient rating is CMS’s survey score (0 to 100) where CMS publishes one.
The 20 practices with the most GLP-1 prescriptions, of 76 in Philadelphia.
Obesity medicine doctors and endocrinologists in Philadelphia
Clinicians practicing in Philadelphia who list obesity medicine or endocrinology in the national provider registry. A listed specialty is what the clinician reported; it is not proof of board certification.
Weight loss clinics and medical spas in Philadelphia
From open map data (Overture Maps), with what each place’s own website mentions where we read it. A mention is not a check that a place prescribes GLP-1s: ask who the prescribing clinician is and check their license.
GLP‑1 prescribers in Philadelphia by ZIP code
Where the clinicians on this page practice, by the ZIP code of their practice address.
Hospitals where Philadelphia’s GLP‑1 prescribers practice
The hospitals CMS lists for these clinicians, with the hospital’s own CMS ratings. A hospital’s stars rate the hospital, not the clinicians who work there.
Compounding pharmacies in Philadelphia
Pharmacies in Philadelphia registered as compounding pharmacies in the national provider registry, with the state license numbers they report. Being on this list says nothing about GLP-1s. A compounding pharmacy is licensed and inspected by the state board of pharmacy; Pennsylvania has 6 outsourcing facilities (503B) on the FDA register, which the FDA also inspects.
Semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) in Philadelphia
What clinicians in Philadelphia prescribed to Medicare patients in 2024, by brand. Ozempic, Wegovy and Rybelsus are semaglutide; Mounjaro and Zepbound are tirzepatide.
Paying yourself? Compare compounded semaglutide programs, compounded tirzepatide programs and the programs for Zepbound, Wegovy and Ozempic.
In person in Philadelphia or online: how they compare
Compounded GLP-1s are prepared by a pharmacy to a prescription. They are not FDA-approved: the FDA doesn’t review their safety, effectiveness or quality before they’re sold, and they are not the same as Wegovy or Zepbound.
Does Pennsylvania Medical Assistance cover GLP‑1s for weight loss?
Since January 1, 2026, Pennsylvania Medical Assistance does not cover any drug containing a GLP-1 receptor agonist for the treatment of overweight or obesity, in both fee-for-service and managed care. Saxenda is no longer covered for any use. GLP-1 drugs stay covered with prior authorization for other medically accepted uses, and obesity drugs without a GLP-1, such as phentermine, are still covered.
Checked November 10, 2026 against the state’s own documents. GLP-1 coverage in Pennsylvania: Medicaid, the state employee plan and Medicare, with sources
GLP‑1 doctors in Philadelphia: questions
Nearby cities
- Trenton, NJ25 mi
- Allentown, PA44 mi
- Bethlehem, PA44 mi
- Reading, PA48 mi
- Elizabeth, NJ67 mi
- Newark, NJ71 mi
Other cities in Pennsylvania
- 1.Ahrefs Keywords Explorer, US, Matching terms, intent = Local, volume >= 40Ahrefsretrieved 2026-11-18
- 2.2025 Gazetteer Files: PlacesUS Census Bureauretrieved 2026-11-18
- 3.Census Geocoder, batch address locations (Public_AR_Current)US Census Bureauretrieved 2026-11-18
- 4.City and Town Population Totals, Vintage 2025 (SUB-EST2025)US Census Bureauretrieved 2026-11-18
- 5.Cartographic Boundary File, Places, 2025, 1:500,000 (cb_2025_us_place_500k)US Census Bureauretrieved 2026-11-18
- 6.2020 ZCTA to Place Relationship FileUS Census Bureauretrieved 2026-11-18
- 7.Clinic websites (homepage + one GLP-1 page)each clinicretrieved 2026-11-18
- 8.Facility Affiliation Data (27ea-46a8)CMS Provider Data Catalogretrieved 2026-11-18
- 9.PY 2024 Clinician Public Reporting: MIPS Measures and Attestations (7d6a-e7a6)CMS Provider Data Catalogretrieved 2026-11-18
- 10.Doctors and Clinicians National Downloadable File (mj5m-pzi6), modified 2026-10-30CMS Provider Data Catalogretrieved 2026-11-18
- 11.PY 2024 Group Public Reporting: Patient Experience (8c70-d353)CMS Provider Data Catalogretrieved 2026-11-18
- 12.PY 2024 Group Public Reporting: MIPS Measures and Attestations (0ba7-2cb0)CMS Provider Data Catalogretrieved 2026-11-18
- 13.Patient survey (HCAHPS) - Hospital (dgck-syfz)CMS Provider Data Catalogretrieved 2026-11-18
- 14.Hospital General Information (xubh-q36u)CMS Provider Data Catalogretrieved 2026-11-18
- 15.PY 2024 Clinician Public Reporting: Overall MIPS Performance (a174-a962)CMS Provider Data Catalogretrieved 2026-11-18
- 16.Medicare Part D Prescribers - by Provider and Drug, data year 2024CMSretrieved 2026-11-18
- 17.Registered Outsourcing Facilities (503B)US FDAretrieved 2026-11-18
- 18.NPPES Data Dissemination, November 2026 (V2)CMSretrieved 2026-11-18
- 19.NUCC Health Care Provider Taxonomy code set v26.1National Uniform Claim Committeeretrieved 2026-11-18
- 20.Open Payments General Payment Data, program year 2025 (published 2026-06-30)CMSretrieved 2026-11-18
- 21.Overture Maps Places, release 2026-10-21.0Overture Maps Foundationretrieved 2026-11-18
- 22.Wikidata (matched on GNIS ID, P590) and Wikimedia CommonsWikimediaretrieved 2026-11-18
Data read November 18, 2026. Clinicians, practices and pharmacies come from public CMS and NPPES files; clinics and medical spas from open map data (Overture Maps). We do not verify that a clinician or clinic offers GLP-1 treatment or takes new patients: call first. This page is educational and is not medical advice. How we built this directory